Question 1

Am I eligible to participate based on my health history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

Question 2

How does PTX-COVID19-B compare to other booster options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of this new booster vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the vaccination process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to travel for any part of this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older clinical trial (NCT05534035). Contact the study team or your healthcare provider for specific answers.

What this study is about